Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis

NCT ID: NCT03930654

Last Updated: 2022-08-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-13

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

African American (AA) women are more vulnerable to HIV infection than other women. Truvada, when used as pre-exposure prophylaxis (PrEP), is one of the most effective approaches for HIV prevention; however, PrEP use among AA women remains low and has not responded to traditional interventions. This study proposes for the first time an innovative computer-based motivational intervention, increasing PrEP uptake (iPrEP), which couples motivational messages woven into a traditional survey to raise awareness of risky sex and substance use behaviors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Patients will be assigned to either an intervention or usual care

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

iPrEP Intervention

iPrEP Intervention:

* Women will receive the iPrEP intervention on an iPAD Air tablet device
* iPrEP serves a dual role as a data collection instrument and an intervention--the survey incorporates brief, informational messages into a traditional survey instrument
* iPrEP uses qualitative themes
* iPrEP is divided into sections addressing factors with historical success at predicting pre-exposure prophylaxis (PrEP) adherence
* Scales chosen to measure themes and sections were retained from the original HIV Prevention Trials Network (HPTN) 073 instrument
* Scales were modified (in some cases) for cultural competency and tailoring to women

Group Type EXPERIMENTAL

iPrEP

Intervention Type BEHAVIORAL

* iPrEP transforms the standard emergency department (ED) visit experience through an intervention presented as a standard assessment that is equipped to: 1) increase knowledge of HIV transmission and 2) provide information on how to reduce an individual's risk for HIV.
* Women will receive the iPrEP intervention on an iPAD Air tablet device
* iPrEP serves a dual role as a data collection instrument and an intervention--the survey incorporates brief, informational messages into a traditional survey instrument
* iPrEP uses qualitative themes
* iPrEP is divided into sections addressing factors with historical success at predicting pre-exposure prophylaxis (PrEP) adherence
* Scales chosen to measure themes and sections were retained from the original HIV Prevention Trials Network (HPTN) 073 instrument
* Scales were modified (in some cases) for cultural competency and tailoring to women

Usual Care

Intervention Type BEHAVIORAL

* Women will receive usual care
* Usual care includes an assessment visit with an emergency department (ED)-assigned social worker who specializes in substance use
* Social worker will offer a list of substance abuse treatment referral agencies

Usual Care

Control Intervention:

* Women will receive usual care
* Usual care includes an assessment visit with an emergency department (ED)-assigned social worker who specializes in substance use
* Social worker will offer a list of substance abuse treatment referral agencies

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type BEHAVIORAL

* Women will receive usual care
* Usual care includes an assessment visit with an emergency department (ED)-assigned social worker who specializes in substance use
* Social worker will offer a list of substance abuse treatment referral agencies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iPrEP

* iPrEP transforms the standard emergency department (ED) visit experience through an intervention presented as a standard assessment that is equipped to: 1) increase knowledge of HIV transmission and 2) provide information on how to reduce an individual's risk for HIV.
* Women will receive the iPrEP intervention on an iPAD Air tablet device
* iPrEP serves a dual role as a data collection instrument and an intervention--the survey incorporates brief, informational messages into a traditional survey instrument
* iPrEP uses qualitative themes
* iPrEP is divided into sections addressing factors with historical success at predicting pre-exposure prophylaxis (PrEP) adherence
* Scales chosen to measure themes and sections were retained from the original HIV Prevention Trials Network (HPTN) 073 instrument
* Scales were modified (in some cases) for cultural competency and tailoring to women

Intervention Type BEHAVIORAL

Usual Care

* Women will receive usual care
* Usual care includes an assessment visit with an emergency department (ED)-assigned social worker who specializes in substance use
* Social worker will offer a list of substance abuse treatment referral agencies

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current HIV negative status (based on ED' HIV test outcome)
* Condomless sex in the last 3 months
* Substance use in the last 3 months
* HIV testing during ED visit (usual care)
* Has a non-emergent health condition
* Has a working mobile device with them

Exclusion Criteria

* Ineligible for PrEP (see eligibility criteria to the right)
* Assigned male at birth
* An HIV positive status
* Currently taking medication that are known contraindications for PrEP (brand name: Truvada)
* Currently on PrEP
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mandy Hill

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mandy J Hill, DrPH, MPH

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center, Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hill MJ, Heads AM, Suchting R, Stotts AL. A survey with interventional components delivered on tablet devices versus usual care to increase pre-exposure prophylaxis uptake among cisgender Black women: a pilot randomized controlled trial. BMC Infect Dis. 2023 Jan 27;23(1):57. doi: 10.1186/s12879-023-08019-z.

Reference Type DERIVED
PMID: 36707778 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSC-MS-16-0892

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Linking Women to PrEP Care
NCT03281343 UNKNOWN NA
A Women-Focused PrEP Intervention
NCT03699722 COMPLETED PHASE1